Clinical Trial Update: Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT) [NA]

View source ↗

Summary

Completed randomized controlled trial MERIT evaluated metacognitive and insight therapy for schizophrenia spectrum disorders; results have been posted as of Mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Schizophrenia Spectrum Disorders

Drugs mentioned

• Metacognitive and Insight Therapy (MERIT)

Snippet

Sponsor: Bar-Ilan University, Israel | Conditions: Diagnosis of Schizophrenia Spectrum Disorders | NA | Status: COMPLETED | Results posted: 2025-03-06